Literature DB >> 1958561

Comparison of the effects of high dose testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men.

K E Friedl1, J R Dettori, C J Hannan, T H Patience, S R Plymate.   

Abstract

We examined the extent to which supraphysiological doses of androgen can modify body composition and strength in normally virilized men. In doubly blind tests, 30 healthy young men received testosterone enanthate (TE) or 19-nortestosterone decanoate (ND), at 100 mg/wk or 300 mg/wk for 6 weeks. The TE-100 mg/wk group served as replacement dose comparison, maintaining pretreatment serum testosterone levels, while keeping all subjects blinded to treatment, particularly through reduction in testicular volumes. Isokinetic strength measurements were made for the biceps brachii and quadriceps femoris muscle groups before treatment and 2-3 days after the 6th injection. Small improvements were noted in all groups but the changes were highly variable; a trend to greater and more consistent strength gain occurred in the TE-300 mg/wk group. There was no change in weight for TE-100 mg/wk but an average gain of 3 kg in each of the other groups. No changes in 4 skinfold thicknesses or in estimated percent body fat were observed. Of 15 circumferences, significant increases were observed only for men receiving TE-300 mg/wk (shoulders) and ND-300 mg/wk (shoulders and chest). The data suggest that high dose androgens increase body mass and may increase strength in normal men but, except for a consistent weight gain with greater than replacement doses, the detectable changes were highly variable and relatively small, especially in comparison to the significant alterations which were observed for other markers of androgen action.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958561     DOI: 10.1016/0960-0760(91)90283-b

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  13 in total

Review 1.  Morphological evolution of athletes over the 20th century: causes and consequences.

Authors:  K Norton; T Olds
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects.

Authors:  Norbert Baume; Yorck Olaf Schumacher; Pierre-Edouard Sottas; Carlo Bagutti; Michel Cauderay; Patrice Mangin; Martial Saugy
Journal:  Eur J Appl Physiol       Date:  2006-08-03       Impact factor: 3.078

Review 3.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 4.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 5.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 6.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 7.  Exercise, Training, and the Hypothalamic-Pituitary-Gonadal Axis in Men and Women.

Authors:  Natalia Cano Sokoloff; Madhusmita Misra; Kathryn E Ackerman
Journal:  Front Horm Res       Date:  2016-06-27       Impact factor: 2.606

Review 8.  Anabolic-androgenic steroids. Current issues.

Authors:  C E Yesalis; M S Bahrke
Journal:  Sports Med       Date:  1995-05       Impact factor: 11.136

Review 9.  Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement.

Authors:  F Kadi
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

10.  Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Authors:  F Hartgens; G Rietjens; H A Keizer; H Kuipers; B H R Wolffenbuttel
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.